Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600867 stock hub

SHA/600867 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600867is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.7B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600867

In the news

Latest news · SHA/600867

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.5

P25 17.1P50 24.2P75 37.8

Trailing P/E15

P25 23.5P50 41.3P75 83.2

ROE17.6

P25 -0.9P50 4.1P75 8.8

ROIC8.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600867 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CNY

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,410
Employees Change	214%
Employees Change Percent	6.7
Enterprise value	CNY 16.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000H87
Last refreshed	2026-05-10
Market cap	CNY 17.7B
Price	CNY 9.09
Price currency	CNY
Rev Per Employee	892,486.22x
Sector	Healthcare
Sic	2834
Symbol	sha/600867
Website	https://www.thdb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7%
EV Earnings	13.38x
EV/EBIT	25.43x
EV/EBITDA	17.62x
EV/FCF	51.28x
EV/Sales	5.44x
FCF yield	1.83%
Forward P/E	27.55x
P/B ratio	2.44x
P/E ratio	14.99x
P/S ratio	5.8x
PE Ratio10 Y	31.28x
PE Ratio3 Y	25.02x
PE Ratio5 Y	20.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.38%
EBITDA Margin	30.61%
FCF margin	10.6%
Gross margin	70.48%
Gross Profit	CNY 2.1B
Gross Profit Growth	48.08%
Gross Profit Growth Q	18.57%
Gross Profit Growth3 Y	3.59%
Gross Profit Growth5 Y	-2.37%
Net Income	CNY 1.2B
Net Income Growth Q	16.16%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	7.3%
Net Income Growth5 Y	4.57%
Pretax Margin	50.25%
Profit Margin	40.64%
Profit Per Employee	CNY 362,665
Profitable Years	1
ROA	5.15
Roa5y	7.52
ROCE	8.54
ROE	17.63
Roe5y	16.21
ROIC	8.42
Roic5y	12.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.54%
Cagr15y	8.16%
Cagr1y	27.44%
Cagr20y	16.45%
Cagr3y	-4.76%
Cagr5y	-3.61%
Div CAGR10	6.05%
Div CAGR3	-20.63%
Div CAGR5	3.55%
EPS Growth Years	1
EPS Growth3 Y	6.19
EPS Growth5 Y	4.38
FCF Growth Q	1,318.66%
FCF Growth3 Y	14.88%
FCF Growth5 Y	-17.69%
OCF Growth	109.07%
OCF Growth Q	165.54%
OCF Growth10 Y	9.03%
OCF Growth3 Y	8.61%
OCF Growth5 Y	-6.69%
Revenue Growth	47.04x
Revenue Growth Q	14.76x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	5.99x
Revenue Growth5 Y	0.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.39
Assets	CNY 8.3B
Cash	CNY 1.8B
Current Assets	CNY 3.1B
Current Liabilities	CNY 631.9M
Debt	CNY 683.6M
Debt EBITDA	CNY 0.73
Debt Equity	CNY 0.09
Debt FCF	CNY 2.12
Equity	CNY 7.2B
Interest Coverage	29.83
Liabilities	CNY 1B
Long Term Assets	CNY 5.2B
Long Term Liabilities	CNY 380.3M
Net Cash	CNY 1.1B
Net Cash By Market Cap	CNY 6.35
Net Debt EBITDA	CNY -1.2
Net Debt Equity	CNY -0.15
Net Debt FCF	CNY -3.48
Tangible Book Value	CNY 6.7B
Tangible Book Value Per Share	CNY 3.16
WACC	5.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.84
Inventory Turnover	1.3
Net Working Capital	CNY 967.8M
Quick ratio	3.61
Working Capital	CNY 2.4B
Working Capital Turnover	CNY 1.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.21%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.3
Dividend Years	14
Dividend Yield	3.3%
Ex Div Date	2025-06-25
Last Dividend	CNY 0.25
Payout Frequency	Annual
Payout Ratio	40.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-22.71%
1Y total return	27.42%
200-day SMA	8.77
3Y total return	-13.61%
50-day SMA	9.32
50-day SMA vs 200-day SMA	50over200
5Y total return	-16.79%
All Time High	27.51
All Time High Change	-66.96%
All Time High Date	2018-05-29
All Time Low	0.37
All Time Low Change	2,366.76%
All Time Low Date	2005-07-18
ATR	0.36
Beta	0.22
Beta1y	0.16
Beta2y	0.41
Ch YTD	11.26
High	9.24
High52	10.67
High52 Date	2026-04-15
High52ch	-14.81%
Low	9.07
Low52	7.34
Low52 Date	2025-05-08
Low52ch	23.84%
Ma50ch	-2.42%
Price vs 200-day SMA	3.64%
RSI	41.21
RSI Monthly	51.68
RSI Weekly	51.18
Sharpe ratio	0.94x
Sortino ratio	1.7
Total Return	4.51%
Tr YTD	11.26
Tr15y	224.48%
Tr1m	-9.01%
Tr1w	-2.36%
Tr3m	2.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 650.6M
Operating Income Growth Q	74.13
Operating Income Growth3 Y	-2.81
Operating Income Growth5 Y	-11.65
Operating margin	21.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,039,682,053%
Net Borrowing	-141,104,409
Shares Insiders	1%
Shares Institutions	11.29%
Shares Out	1,943,465,012
Shares Qo Q	8.25%
Shares Yo Y	-1.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 322.6M
Average Volume	71,492,119.95x
Bv Per Share	3.43
CAPEX	CNY -530.5M
Ch10y	-37.19
Ch15y	148.1
Ch1m	-9.01
Ch1w	-2.36
Ch1y	23.34
Ch20y	1,506.6
Ch3m	2.02
Ch3y	-20.33
Ch5y	-28.76
Ch6m	-0.55
Change	-1.2%
Change From Open	-1.3
Close	9.2
Days Gap	0.11
Depreciation Amortization	280,881,336
Dollar Volume	303,377,168.3
Earnings Date	2026-04-20
EBIT	CNY 650.6M
EBITDA	CNY 931.5M
EPS	CNY 0.61
F Score	6
FCF	CNY 322.6M
FCF EV Yield	1.95x
FCF Per Share	CNY 0.17
Financing CF	-599,846,800
Fiscal Year End	December
Founded	1,985
Graham Number	6.83625
Graham Upside	-24.79
Income Tax	CNY 317.5M
Investing CF	779,942,770
Is Primary Listing	1
Last Earnings Date	2026-04-20
Last Report Date	2026-03-31
Last Split Date	2018-05-25
Last Split Type	Forward
Lynch Fair Value	CNY 3.03
Lynch Upside	-66.65
Ma150	8.9
Ma150ch	2.12%
Ma20	9.78
Ma20ch	-7.01%
Net CF	1,033,230,626
Next Earnings Date	2026-08-24
Open	9.21
P FCF Ratio	54.76
P OCF Ratio	20.71
Payment Date	2025-06-25
Position In Range	11.76
Ppne	2,431,023,173
Price Date	2026-05-08
Price EBITDA	CNY 18.96
Ptbv Ratio	2.64
Relative Volume	0.47x
Revenue	3,043,378,022x
Tax By Revenue	10.43x
Tax Rate	20.76%
Tr20y	2,001.07%
Tr6m	-0.55%
Volume	33,374,826

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600867 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$0.30 annual per share

Payout ratio

+40.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.5%

0 consecutive years of growth

Total shareholder yield

+4.5%

Next ex-dividend date: 2025-06-25

Performance

SHA/600867 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600867?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.3%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.2%

Negative means the company is buying back shares.

Technical

SHA/600867 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.2

Neutral momentum band

Price vs 200-day MA

+3.6%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600867

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600867 stock rating?

sha/600867 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600867 analysis?

The full report lives at /stocks/sha/600867/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600867?

The latest report frames sha/600867 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600867 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.